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Background:Calcification is a key process in the pathogenesis of aortic stenosis and its activity in the valve can be measured using the positron-
emission-tomography (PET) tracer 18F-sodium fluoride (18F-NaF). We sought to assess whether 18F-NaF PET predicts progression and outcomes in 
aortic stenosis.
Methods: We prospectively enrolled 121 volunteers (72±8 years, 68% men) with and without aortic stenosis (20 controls; 20 aortic sclerosis; 
25 mild, 33 moderate, and 23 severe aortic stenosis). At enrolment, all subjects underwent PET/CT scanning using 18F-NaF (125MBq) with 
echocardiography and CT calcium scoring of the valve performed at baseline and 2 years. The need for aortic valve replacement (AVR) and the 
incidence of cardiovascular death during the follow up period were recorded.
results:Five patients died from a cardiovascular cause, 17 had an AVR and 99 subjects underwent repeat echocardiography and 77 repeat 
calcium scoring at 2 years. The severity of aortic stenosis progressed with an increase in peak aortic jet velocity of 0.17 (median; IQR -0.03-0.37) 
m/s, (p<0.001) and CT calcium score of 133 (median; IQR 10-493) Agatston units (p<0.001). A strong correlation was observed between baseline 
valvular 18F-NaF uptake (mean tissue-to-background ratio) and the progression in calcium score (r=0.78, p=<0.001). Moderate correlations were 
observed between 18F-NaF activity and echocardiographic measures of hemodynamic progression: change in peak velocity (r=0.21, p=0.03), mean 
gradient (r=0.29, p=0.003) and peak gradient (r=0.29, p=0.004). After adjustment for age and sex, valvular 18F-NaF emerged as an independent 
predictor of AVR / cardiovascular mortality (RR 1.19 (1.08-1.27), p=<0.001 per 0.1 unit increment in 18F-NaF).
conclusions:18F-NaF holds promise as a predictor of disease progression and adverse clinical events in patients with aortic stenosis.
